report banner

News in English

PostNews
biostock-phi-grows-its-network-of-collaborations-wheels-in-motion

BioStock: PHI grows its network of collaborations

BioStock caught up with PHI’s CEO Patrik Eschricht to ask about his outlook for the growing number of academic collaborations and sales partnerships.
Learn more …
PostNews: Press Release
kem-en-tec-nordic-logo

PHI bolsters Nordic sales presence with new distribution agreement between Altium and Kem-En-Tec Nordic

PHI is pleased to announce a new distribution agreement between its global distribution partner, Altium, and Kem-En-Tec Nordic, a lab supplier dedicated to supporting BioScience labs in Denmark, Sweden, Norway, Finland and Iceland.
Learn more …
PostNews: Press Release
Paralab-logo

PHI expands to Spanish and Portuguese markets through Altium’s new subcontract with Paralab

PHI is pleased to announce a strategic expansion into the Spanish and Portuguese markets, facilitated by a new subcontract between its global distribution partner, Altium, and Paralab.
Learn more …
PostNews: Press Release
blue-cells_white-bg_banner

PHI partners with University College London to use HoloMonitor in a first clinical research project

PHI is excited to announce a strategic partnership with University College London (UCL). Under this collaboration, PHI will lend a HoloMonitor® M4FL system for use in an ongoing research project at UCL, which runs alongside a clinical trial. This partnership represents PHI’s first direct step in a hospital setting to explore the clinical applications of its innovative technology.
Learn more …
PostNews: Press Release

PHI terminates agreement regarding liquidity provider

PHI today announces that the Company has terminated the liquidity provider agreement with Pareto Securities AB. The agreement will expire on July 31, 2024.
Learn more …
PostNews
phi-right-moment-to-capitalize-on-regenerative-medicine-momentum

BioStock: PHI “It’s the right moment to capitalize on regenerative medicine momentum.”

BioStock contacted CEO Patrik Eschricht for an update on the company’s progress and how PHI will capitalize on the current momentum.
Learn more …
12334